Predicted protein targets (top 9)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | GLS | O94925 | 3/20 | 0.42 |
| ▸ | MAOB | P27338 | 2/20 | 0.41 |
| ▸ | NOS1 | P29475 | 1/20 | 0.41 |
| ▸ | NOS2 | P35228 | 1/20 | 0.41 |
| ▸ | PRSS1 | P07477 | 6/20 | 0.41 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.40 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.40 |
| ▸ | TSHR | P16473 | 1/20 | 0.40 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.39 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL3759807 | 0.98 | PRSS1 (0.42) | GLSMAOBNOS1NOS2PRSS1 | |
| SCHEMBL3764561 | 0.98 | PRSS1 (0.42) | GLSMAOBNOS1NOS2PRSS1 | |
| SCHEMBL3760044 | 0.95 | L3MBTL1 (0.43) | GLSMAOBNOS1NOS2PRSS1 | |
| SCHEMBL3766493 | 0.90 | MAOB (0.43) | GLSMAOBNOS1NOS2KDM4E | |
| SCHEMBL17138168 | 0.85 | KCNA3 (0.46) | MAOBPRSS1ALDH1A1KDM4ETSHR | |
| SCHEMBL12408537 | 0.85 | PRSS1 (0.51) | MAOBNOS1NOS2PRSS1ALDH1A1 | |
| SCHEMBL17138208 | 0.83 | PRSS1 (0.46) | MAOBPRSS1ALDH1A1KDM4ETSHR | |
| SCHEMBL3770972 | 0.82 | PPARA (0.42) | MAOBNOS1NOS2PRSS1ALDH1A1 | |
| SCHEMBL3764400 | 0.81 | PPARA (0.44) | MAOBPRSS1ALDH1A1KDM4ETSHR | |
| SCHEMBL3769700 | 0.81 | PPARA (0.47) | MAOBALDH1A1KDM4ETSHRL3MBTL1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20100311790-A1 | AMIDE COMPOUNDS AND PLANT DISEASE CONTROLLING METHOD USING SAME | SUMITOMO CHIEMCAL COMPANY LIMITED (JP) | 2010-12-09 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20100311790-A1 | AMIDE COMPOUNDS AND PLANT DISEASE CONTROLLING METHOD USING SAME | ATL3, NAT1, C5 | GLS 1313/4885MAOB 667/4885NOS1 2162/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.